Please provide your email address to receive an email when new articles are posted on . CHARLOTTE, N.C. — Patient-reported outcomes of abdominal pain and stool frequency improved with risankizumab ...

Please provide your email address to receive an email when new articles are posted on . The percentage of patients with clinical remission, evaluated with the three component Mayo score, served as the ...

POTOMAC data support a year's worth of immuontherapy paired with BCG induction and mainten ...

Findings from the primary analysis of the phase 3b PATAPSCO study showed that adding durvalumab (Imfinzi) to BCG induction ...

Organization of Cancer Specialists in US Physician Practices and Health Systems After dose escalation, 120 mg gilteritinib once daily was chosen for further study. There were 58 participants evaluable ...

Forkhead Box Protein P1 Expression in Mucosa-Associated Lymphoid Tissue Lymphomas Predicts Poor Prognosis and Transformation to Diffuse Large B-Cell Lymphoma The complete remission rate in patients ...

While there is no cure for ANCA-associated vasculitis (AAV), treatment is usually very effective at bringing it under control and preventing life-threatening complications. This group of rare ...

RIO DE JANEIRO — The addition of daratumumab to lenalidomide maintenance therapy following autologous stem cell transplant (ASCT) significantly improves rates of achieving minimal residual disease ...